CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Pharma
Original article

BD Reports Third Quarter Fiscal 2026 Financial Results

EarningsPositive
AI Analysis

Summary

BD reported third quarter fiscal 2026 earnings with revenue of $5.0 billion, up 4.4% on a currency-neutral basis, and adjusted diluted EPS of $3.23. Year-to-date cash from continuing operations increased 33.3% to $2.1 billion with free cash flow up 44.6% to $1.7 billion.

Financial Highlights

Revenue

$5.0 billion, +5.4% as reported, +4.4% FXN

EPS

GAAP $1.64, Adjusted $3.23

Importance:3/10
Sentiment:
0.30
EarningsQ3 FY2026Revenue GrowthCash Flow
Related Companies

Read the original article

Published by PR Newswire Pharma on August 6, 2026 10:30 AM

Read Original